Skip to main content
Figure 5 | BMC Gastroenterology

Figure 5

From: Reduction of novel circulating long-chain fatty acids in colorectal cancer patients is independent of tumor burden and correlates with age

Figure 5

Longitudinal CRC-446 levels in stage IV metastatic CRC patients. Levels of CRC-446 at multiple timepoints up to 63 weeks are shown for 12 stage IV metastatic CRC patients enrolled in a clinical trial for an experimental cancer vaccine. The y-axes are scaled equivalently to Figure 4 for comparison and the dotted lines represent the mean CRC-446 concentration in CRC-positive subjects of 0.15 ug/ml CAEs for reference.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us